Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in children.
Identifieur interne : 003594 ( PubMed/Corpus ); précédent : 003593; suivant : 003595Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in children.
Auteurs : María Consuelo Escamilla-Nu Ez ; Albino Barraza-Villarreal ; Leticia Hernández-Cadena ; Efraín Navarro-Olivos ; Peter D. Sly ; Isabelle RomieuSource :
- Chest [ 1931-3543 ] ; 2014.
English descriptors
- KwdEn :
- Adolescent, Adult, Dietary Supplements, Dose-Response Relationship, Drug, Double-Blind Method, Fatty Acids, Omega-3 (administration & dosage), Female, Follow-Up Studies, France, Gestational Age, Humans, Incidence, Infant, Infant, Newborn, Male, Pregnancy, Pregnancy Complications (prevention & control), Pregnancy Outcome, Premature Birth (prevention & control), Prenatal Care (methods), Prenatal Nutritional Physiological Phenomena, Respiratory Distress Syndrome, Newborn (epidemiology), Respiratory Distress Syndrome, Newborn (prevention & control), Treatment Outcome, Young Adult.
- MESH :
- chemical , administration & dosage : Fatty Acids, Omega-3.
- geographic : France.
- epidemiology : Respiratory Distress Syndrome, Newborn.
- methods : Prenatal Care.
- prevention & control : Pregnancy Complications, Premature Birth, Respiratory Distress Syndrome, Newborn.
- Adolescent, Adult, Dietary Supplements, Dose-Response Relationship, Drug, Double-Blind Method, Female, Follow-Up Studies, Gestational Age, Humans, Incidence, Infant, Infant, Newborn, Male, Pregnancy, Pregnancy Outcome, Prenatal Nutritional Physiological Phenomena, Treatment Outcome, Young Adult.
Abstract
Prenatal consumption of omega-3 fatty acids can act as an adjuvant in the development of the immune system and affect the inflammatory response of neonates.
DOI: 10.1378/chest.13-1432
PubMed: 24626819
Links to Exploration step
pubmed:24626819Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in children.</title><author><name sortKey="Escamilla Nu Ez, Maria Consuelo" sort="Escamilla Nu Ez, Maria Consuelo" uniqKey="Escamilla Nu Ez M" first="María Consuelo" last="Escamilla-Nu Ez">María Consuelo Escamilla-Nu Ez</name><affiliation><nlm:affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.</nlm:affiliation></affiliation></author><author><name sortKey="Barraza Villarreal, Albino" sort="Barraza Villarreal, Albino" uniqKey="Barraza Villarreal A" first="Albino" last="Barraza-Villarreal">Albino Barraza-Villarreal</name><affiliation><nlm:affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico. Electronic address: abarraza@correo.insp.mx.</nlm:affiliation></affiliation></author><author><name sortKey="Hernandez Cadena, Leticia" sort="Hernandez Cadena, Leticia" uniqKey="Hernandez Cadena L" first="Leticia" last="Hernández-Cadena">Leticia Hernández-Cadena</name><affiliation><nlm:affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.</nlm:affiliation></affiliation></author><author><name sortKey="Navarro Olivos, Efrain" sort="Navarro Olivos, Efrain" uniqKey="Navarro Olivos E" first="Efraín" last="Navarro-Olivos">Efraín Navarro-Olivos</name><affiliation><nlm:affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.</nlm:affiliation></affiliation></author><author><name sortKey="Sly, Peter D" sort="Sly, Peter D" uniqKey="Sly P" first="Peter D" last="Sly">Peter D. Sly</name><affiliation><nlm:affiliation>World Health Organization Collaborating Centre for Research and Children's Environmental Health, Curtin University of Technology and Centre for Child of Western Australia, Perth, WA, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Romieu, Isabelle" sort="Romieu, Isabelle" uniqKey="Romieu I" first="Isabelle" last="Romieu">Isabelle Romieu</name><affiliation><nlm:affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico; International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24626819</idno><idno type="pmid">24626819</idno><idno type="doi">10.1378/chest.13-1432</idno><idno type="wicri:Area/PubMed/Corpus">003594</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003594</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in children.</title><author><name sortKey="Escamilla Nu Ez, Maria Consuelo" sort="Escamilla Nu Ez, Maria Consuelo" uniqKey="Escamilla Nu Ez M" first="María Consuelo" last="Escamilla-Nu Ez">María Consuelo Escamilla-Nu Ez</name><affiliation><nlm:affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.</nlm:affiliation></affiliation></author><author><name sortKey="Barraza Villarreal, Albino" sort="Barraza Villarreal, Albino" uniqKey="Barraza Villarreal A" first="Albino" last="Barraza-Villarreal">Albino Barraza-Villarreal</name><affiliation><nlm:affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico. Electronic address: abarraza@correo.insp.mx.</nlm:affiliation></affiliation></author><author><name sortKey="Hernandez Cadena, Leticia" sort="Hernandez Cadena, Leticia" uniqKey="Hernandez Cadena L" first="Leticia" last="Hernández-Cadena">Leticia Hernández-Cadena</name><affiliation><nlm:affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.</nlm:affiliation></affiliation></author><author><name sortKey="Navarro Olivos, Efrain" sort="Navarro Olivos, Efrain" uniqKey="Navarro Olivos E" first="Efraín" last="Navarro-Olivos">Efraín Navarro-Olivos</name><affiliation><nlm:affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.</nlm:affiliation></affiliation></author><author><name sortKey="Sly, Peter D" sort="Sly, Peter D" uniqKey="Sly P" first="Peter D" last="Sly">Peter D. Sly</name><affiliation><nlm:affiliation>World Health Organization Collaborating Centre for Research and Children's Environmental Health, Curtin University of Technology and Centre for Child of Western Australia, Perth, WA, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Romieu, Isabelle" sort="Romieu, Isabelle" uniqKey="Romieu I" first="Isabelle" last="Romieu">Isabelle Romieu</name><affiliation><nlm:affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico; International Agency for Research on Cancer, Lyon, France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Chest</title><idno type="eISSN">1931-3543</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Dietary Supplements</term><term>Dose-Response Relationship, Drug</term><term>Double-Blind Method</term><term>Fatty Acids, Omega-3 (administration & dosage)</term><term>Female</term><term>Follow-Up Studies</term><term>France</term><term>Gestational Age</term><term>Humans</term><term>Incidence</term><term>Infant</term><term>Infant, Newborn</term><term>Male</term><term>Pregnancy</term><term>Pregnancy Complications (prevention & control)</term><term>Pregnancy Outcome</term><term>Premature Birth (prevention & control)</term><term>Prenatal Care (methods)</term><term>Prenatal Nutritional Physiological Phenomena</term><term>Respiratory Distress Syndrome, Newborn (epidemiology)</term><term>Respiratory Distress Syndrome, Newborn (prevention & control)</term><term>Treatment Outcome</term><term>Young Adult</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Fatty Acids, Omega-3</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Respiratory Distress Syndrome, Newborn</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Prenatal Care</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pregnancy Complications</term><term>Premature Birth</term><term>Respiratory Distress Syndrome, Newborn</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Dietary Supplements</term><term>Dose-Response Relationship, Drug</term><term>Double-Blind Method</term><term>Female</term><term>Follow-Up Studies</term><term>Gestational Age</term><term>Humans</term><term>Incidence</term><term>Infant</term><term>Infant, Newborn</term><term>Male</term><term>Pregnancy</term><term>Pregnancy Outcome</term><term>Prenatal Nutritional Physiological Phenomena</term><term>Treatment Outcome</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Prenatal consumption of omega-3 fatty acids can act as an adjuvant in the development of the immune system and affect the inflammatory response of neonates.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24626819</PMID><DateCreated><Year>2014</Year><Month>08</Month><Day>06</Day></DateCreated><DateCompleted><Year>2014</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2017</Year><Month>05</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1931-3543</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><Issue>2</Issue><PubDate><Year>2014</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in children.</ArticleTitle><Pagination><MedlinePgn>373-382</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0012-3692(15)48826-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1378/chest.13-1432</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Prenatal consumption of omega-3 fatty acids can act as an adjuvant in the development of the immune system and affect the inflammatory response of neonates.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a double-blind, randomized, placebo-controlled trial in Cuernavaca, Mexico. We randomly assigned 1,094 pregnant women (18-35 years of age) to receive 400 mg/d of algal docosahexaenoic acid (DHA) or placebo from 18 to 22 weeks of gestation through delivery. Birth outcomes and respiratory symptoms information until 18 months were available for 869 mother-child pairs. Questionnaires were administered, and maternal blood samples were obtained at baseline. Maternal atopy was based on specific IgE levels. During follow-up, information on infants' respiratory symptoms was collected through questionnaires administered at 1, 3, 6, 9, 12, and 18 months of age. Negative binomial regression models were used to evaluate the effect of supplementation on respiratory symptoms in infants.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among infants of atopic mothers, a statistically significant protective effect of DHA treatment was observed on phlegm with nasal discharge or nasal congestion (0.78; 95% CI, 0.60-1.02) and fever with phlegm and nasal discharge or nasal congestion (0.53; 95% CI, 0.29-0.99), adjusting for potential confounders.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results support the hypothesis that DHA supplementation during pregnancy may decrease the incidence of respiratory symptoms in children with a history of maternal atopy.</AbstractText><AbstractText Label="TRIAL REGISTRY" NlmCategory="BACKGROUND">ClinicalTrials.gov; No.: NCT00646360; URL: www.clinicaltrials.gov.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Escamilla-Nuñez</LastName><ForeName>María Consuelo</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barraza-Villarreal</LastName><ForeName>Albino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico. Electronic address: abarraza@correo.insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernández-Cadena</LastName><ForeName>Leticia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro-Olivos</LastName><ForeName>Efraín</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sly</LastName><ForeName>Peter D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>World Health Organization Collaborating Centre for Research and Children's Environmental Health, Curtin University of Technology and Centre for Child of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romieu</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico; International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00646360</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01 HD058818</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015525">Fatty Acids, Omega-3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Lipids. 2007 Sep;42(9):801-10</RefSource><PMID Version="1">17952480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prostaglandins Leukot Essent Fatty Acids. 2007 Nov-Dec;77(5-6):327-35</RefSource><PMID Version="1">18032006</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nutr. 2008 Sep;138(9):1768S-1769S</RefSource><PMID Version="1">18716184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nutr. 2008 Sep;138(9):1770S-1772S</RefSource><PMID Version="1">18716185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nutr. 2008 Sep;138(9):1807S-1812S</RefSource><PMID Version="1">18716191</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pediatr. 2010 Jun;156(6):902-6, 906.e1</RefSource><PMID Version="1">20227721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Food Nutr Bull. 2010 Jun;31(2 Suppl):S108-16</RefSource><PMID Version="1">20715595</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Rev Allergy Immunol. 2011 Aug;41(1):36-66</RefSource><PMID Version="1">19997989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatrics. 2011 Sep;128(3):e505-12</RefSource><PMID Version="1">21807696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Clin Nutr. 2013 Apr;67(4):353-9</RefSource><PMID Version="1">23443828</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2000 Mar 1;9(4):549-59</RefSource><PMID Version="1">10699178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Clin Nutr. 2013 Aug;98(2):480-7</RefSource><PMID Version="1">23761484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Coll Nutr. 1995 Feb;14(1):18-23</RefSource><PMID Version="1">7706605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1985 May 9;312(19):1217-24</RefSource><PMID Version="1">2985986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Allergy Asthma Proc. 2013 Sep-Oct;34(5):e27-34</RefSource><PMID Version="1">23998234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Salud Publica Mex. 1998 Mar-Apr;40(2):133-40</RefSource><PMID Version="1">9617194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Perinat Med. 2007;35 Suppl 1:S12-8</RefSource><PMID Version="1">17302535</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Assoc Thai. 2005 Nov;88 Suppl 8:S149-55</RefSource><PMID Version="1">16856435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lipids. 2005 Jul;40(7):669-76</RefSource><PMID Version="1">16196417</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015525" MajorTopicYN="N">Fatty Acids, Omega-3</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011248" MajorTopicYN="N">Pregnancy Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047928" MajorTopicYN="N">Premature Birth</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011295" MajorTopicYN="N">Prenatal Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039401" MajorTopicYN="N">Prenatal Nutritional Physiological Phenomena</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012127" MajorTopicYN="N">Respiratory Distress Syndrome, Newborn</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC4122276</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24626819</ArticleId><ArticleId IdType="pii">S0012-3692(15)48826-9</ArticleId><ArticleId IdType="doi">10.1378/chest.13-1432</ArticleId><ArticleId IdType="pmc">PMC4122276</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003594 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003594 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:24626819
|texte= Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in children.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24626819" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |